TMC Lice Research, Inc
Welcome,         Profile    Billing    Logout  
 0 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Jacobs, Mark
NCT05303636: LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women

Recruiting
4
1710
US
LF111 (drospirenone 4 mg oral tablet) or drospirenone (DRSP) 3.5 mg chewable tablet
Insud Pharma, Chemo Research
Change in Bone Mineral Density, Bone Loss
07/26
03/27
NCT05461573: Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females

Active, not recruiting
3
1009
US
Drospirenone, LPRI-CF113
Insud Pharma, Chemo Research
Contraception, Change in Bone Mineral Density
05/24
05/25
NCT05399641: Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis

Completed
3
150
US
Ibrexafungerp
Scynexis, Inc.
Vulvovaginal Candidiasis
05/23
08/23
SIS, NCT06597344: A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis)

Recruiting
3
90
US
Gepotidacin
GlaxoSmithKline
Urinary Tract Infections
03/25
03/25
ELENA, NCT05560646: A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

Active, not recruiting
2
380
Europe, US, RoW
OG-6219, Placebo
Organon and Co, Iqvia Pty Ltd
Endometriosis
05/25
05/25

Download Options